Molecular imaging in cognitive impairment: The relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 2, 2010, Pages 399-404

  Lucignani, Giovanni ^a,b   Perneczky, Robert ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; FLUORODEOXYGLUCOSE F 18; GLUCOSE; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; AMNESIA; BRAIN ATROPHY; BRAIN METABOLISM; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EDUCATION; FRONTOTEMPORAL DEMENTIA; GENOTYPE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; LONGITUDINAL STUDY; MINI MENTAL STATE EXAMINATION; MOLECULAR IMAGING; MOTOR DYSFUNCTION; NEOCORTEX; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PROTEIN AGGREGATION; PROTEIN FOLDING; RATING SCALE; REVIEW; STANDARDIZATION; TEMPORAL LOBE;

BRAIN; COGNITION DISORDERS; HUMANS; LONGITUDINAL STUDIES; MOLECULAR PROBE TECHNIQUES; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 77949268978     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1361-0     Document Type: Review

References (17)

1. Diogenes Laertius. Lives of Eminent Philosophers, trans. Robert Drew Hicks. (1925). Loeb Classical Library.
2. A Kurz R Perneczky 2009 Neurobiology of cognitive disorders Curr Opin Psychiatry. 22 6 546 51 10.1097/YCO.0b013e328330588b 19644374
3. R Perneczky S Wagenpfeil KL Lunetta LA Cupples RC Green C Decarli LA Farrer A Kurz 2009 Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer's Disease: the MIRAGE study J Alzheimers Dis. 17 4 855 62
4. R Perneczky P Häussermann A Drzezga H Boecker O Granert R Feurer H Förstl A Kurz 2009 Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve Am J Geriatr Psychiatry. 17 3 188 95 10.1097/JGP.0b013e3181961a6f 19454846
5. R Perneczky A Drzezga H Boecker AO Ceballos-Baumann O Granert H Förstl A Kurz P Häussermann 2008 Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease Dement Geriatr Cogn Disord. 26 5 475 81 10.1159/000167791 1:CAS:528: DC%2BD1cXhtl2qtbnE 18984958
6. R Perneczky C Pohl S Bornschein H Förstl A Kurz J Diehl-Schmid 2009 Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations Eur Arch Psychiatry Clin Neurosci. 259 6 362 7 10.1007/s00406-009-0004-6 19255708
7. Y Stern 2009 Cognitive reserve Neuropsychologia. 47 10 2015 28 10.1016/j.neuropsychologia.2009.03.004 19467352
8. JD Van Horn AW Toga 2009 Multisite neuroimaging trials Curr Opin Neurol. 22 4 370 8 10.1097/WCO.0b013e32832d92de 19506479
9. JB Langbaum K Chen W Lee C Reschke D Bandy AS Fleisher GE Alexander NL Foster MW Weiner RA Koeppe WJ Jagust EM Reiman 2009 Alzheimer's Disease neuroimaging initiative. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Neuroimage. 45 4 1107 16 10.1016/j.neuroimage.2008.12.072 19349228
10. KA Ellis AI Bush D Darby D De Fazio J Foster P Hudson NT Lautenschlager N Lenzo RN Martins P Maruff C Masters A Milner K Pike C Rowe G Savage C Szoeke K Taddei V Villemagne M Woodward D Ames AIBL research group 2009 The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer's disease Int Psychogeriatr. 21 4 672 87 10.1017/S1041610209009405 19470201
11. 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias J Nucl Med. 49 3 390 8 10.2967/jnumed.107.045385 18287270 (Pubitemid 351355204)
12. G Pearlson 2009 Multisite collaborations and large databases in psychiatric neuroimaging: advantages, problems, and challenges Schizophr Bull. 35 1 1 2 10.1093/schbul/sbn166 19023121
13. A Joshi RA Koeppe JA Fessler 2009 Reducing between scanner differences in multi-center PET studies Neuroimage. 46 1 154 9 10.1016/j.neuroimage.2009.01. 057 19457369
14. M Fouquet B Desgranges B Landeau E Duchesnay F Mézenge V de la Sayette F Viader JC Baron F Eustache G Chételat 2009 Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease Brain. 132 Pt 8 2058 67 10.1093/brain/awp132 19477964
15. L Mosconi R Mistur R Switalski WH Tsui L Glodzik Y Li E Pirraglia S De Santi B Reisberg T Wisniewski MJ de Leon 2009 FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease Eur J Nucl Med Mol Imaging. 36 5 811 22 10.1007/s00259-008-1039-z 1:CAS:528:DC%2BD1MXkt1yms7k%3D 19142633
16. CR Jack Jr VJ Lowe SD Weigand HJ Wiste ML Senjem DS Knopman MM Shiung JL Gunter BF Boeve BJ Kemp M Weiner RC Petersen 2009 Alzheimer's disease neuroimaging initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease Brain. 132 Pt 5 1355 65 10.1093/brain/awp062 19339253
17. B Dubois HH Feldman C Jacova ST Dekosky P Barberger-Gateau J Cummings A Delacourte D Galasko S Gauthier G Jicha K Meguro J O'Brien F Pasquier P Robert M Rossor S Salloway Y Stern PJ Visser P Scheltens 2007 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6 8 734 46 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)